Michael Lyons, DPM
Podiatrist · Wabash, INNPI 1922234723
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (34.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Trilliant Surgical LLC. at 28.7% of the total. Reporting peaked in 2020 at $4,616 and has fallen 93.7% since, to $290 in 2025.
Across 79 payments — averaging $132.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trilliant Surgical LLC.$3K
- Arthrex$2K
- Paragon 28, Inc.$2K
- Stryker$2K
- Crossroads Orthopedics, LLC$770
- Smith+Nephew$150
- plus $573 from 12 others
What the payments were for
- Speaking & faculty fees$1,50014%
- Travel & lodging$2,31322%
- Food & beverage$3,07129%
- Education$3,55434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trilliant Surgical LLC. | 2 | $3,000 |
| Arthrex | 4 | $2,337 |
| Paragon 28, Inc. | 19 | $1,980 |
| Stryker | 22 | $1,628 |
| Crossroads Orthopedics, LLC | 5 | $770 |
| Smith+Nephew | 7 | $150 |
| RTI Surgical, Inc | 1 | $131 |
| Bioventus LLC | 2 | $97 |
| Organogenesis Inc. | 2 | $70 |
| GRT US Holding, Inc. | 4 | $66 |
| Kerecis Limited | 1 | $43 |
| Tactile Systems Technology Inc | 3 | $40 |
| Zimmer Biomet | 2 | $32 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Solventum Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,438 in reported general payments places this provider in the 85th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 131 | $1,719 |
| Pregabalin | 63 | $1,499 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $912 |
| Gabapentin | 64 | $673 |
| Clobetasol Propionate | 18 | $437 |
| Doxycycline Hyclate | 29 | $373 |
| Ammonium Lactate | 25 | $371 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $332 |
| Methylprednisolone | 47 | $288 |
| Terbinafine Hcl | 19 | $223 |
| Levofloxacin | 13 | $86 |
| Meloxicam | 24 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Wabash
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
- Townsen KenningtonFort Wayne$20K
- Jared MoonCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.